1. Home
  2. KVYO vs VRNA Comparison

KVYO vs VRNA Comparison

Compare KVYO & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KVYO
  • VRNA
  • Stock Information
  • Founded
  • KVYO 2012
  • VRNA 2005
  • Country
  • KVYO United States
  • VRNA United Kingdom
  • Employees
  • KVYO N/A
  • VRNA N/A
  • Industry
  • KVYO
  • VRNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • KVYO
  • VRNA Health Care
  • Exchange
  • KVYO Nasdaq
  • VRNA Nasdaq
  • Market Cap
  • KVYO 9.4B
  • VRNA 8.3B
  • IPO Year
  • KVYO 2023
  • VRNA 2017
  • Fundamental
  • Price
  • KVYO $29.74
  • VRNA $105.18
  • Analyst Decision
  • KVYO Buy
  • VRNA Buy
  • Analyst Count
  • KVYO 21
  • VRNA 11
  • Target Price
  • KVYO $42.38
  • VRNA $114.10
  • AVG Volume (30 Days)
  • KVYO 1.1M
  • VRNA 8.1M
  • Earning Date
  • KVYO 08-05-2025
  • VRNA 08-11-2025
  • Dividend Yield
  • KVYO N/A
  • VRNA N/A
  • EPS Growth
  • KVYO N/A
  • VRNA N/A
  • EPS
  • KVYO N/A
  • VRNA N/A
  • Revenue
  • KVYO $1,007,298,000.00
  • VRNA $118,535,000.00
  • Revenue This Year
  • KVYO $27.90
  • VRNA $893.95
  • Revenue Next Year
  • KVYO $21.02
  • VRNA $73.76
  • P/E Ratio
  • KVYO N/A
  • VRNA N/A
  • Revenue Growth
  • KVYO 33.95
  • VRNA N/A
  • 52 Week Low
  • KVYO $22.12
  • VRNA $18.51
  • 52 Week High
  • KVYO $49.55
  • VRNA $105.50
  • Technical
  • Relative Strength Index (RSI)
  • KVYO 31.89
  • VRNA 70.25
  • Support Level
  • KVYO $32.26
  • VRNA $104.58
  • Resistance Level
  • KVYO $34.19
  • VRNA $105.31
  • Average True Range (ATR)
  • KVYO 0.98
  • VRNA 0.22
  • MACD
  • KVYO -0.21
  • VRNA -0.64
  • Stochastic Oscillator
  • KVYO 7.48
  • VRNA 60.49

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

Share on Social Networks: